1,856 results match your criteria Chronic Inflammatory Demyelinating Polyradiculoneuropathy


Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.

Neurology 2019 Feb 13. Epub 2019 Feb 13.

From the Department of Neurology (P.S.N.), National Neuroscience Institute, Singapore; Department of Neurology (P.S.N., P.J.D., R.S.L., M.V.P., P.J.B.D.), and Division of Biomedical Statistics and Informatics (P.T.), Mayo Clinic, Rochester, MN.

Objective: To determine the previously unknown incidence of lumbosacral-radiculoplexus neuropathy (LRPN) and its association with diabetes mellitus (DM).

Methods: LRPN defined by clinical and electrophysiologic criteria was identified among Olmsted County, Minnesota, residents during a 16-year period (2000-2015) using the unique facilities of the Rochester Epidemiology Project. DM was ascertained using American Diabetes Association criteria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007020DOI Listing
February 2019
1 Read

Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.

J Neurol 2019 Feb 5. Epub 2019 Feb 5.

Department of Neurosciences, Odontostomatology and Reproductive Sciences, University of Naples " Federico II ", Via Pansini, 5, 81025, Naples, Italy.

Objective: The current clinical measures (ONLS, R-ODS, mRS, and MRC) may not be so sensitive in capturing minimal variations or measuring fatigue in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Our aim was to assess if 6-min walk test (6MWT) is able to increase the sensitivity in detecting response to therapy and to capture fatigue in CIDP patients.

Methods: We tested 6MWT in 42 CIDP patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-019-09207-1DOI Listing
February 2019

Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.

J Neuroimmunol 2019 Jan 29. Epub 2019 Jan 29.

Laboratory of Neuroimmunology, IRCCS Mondino Foundation, Pavia, Italy.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with anti-neurofascin-155 antibodies is a subgroup of CIDP with tremor and poor response to intravenous immunoglobulins. A 23-year-old male presented with a 6-month history ataxic-stepping gait, stocking tactile hypoesthesia, areflexia, tremor at limbs and tongue. Neurophysiology and cerebrospinal fluid analysis supported the diagnosis of CIDP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2019.01.017DOI Listing
January 2019
1 Read

Chronic Immune Sensorimotor Polyradiculopathy (CISMP): Report of a Case Series.

Muscle Nerve 2019 Jan 30. Epub 2019 Jan 30.

Department of Neurology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.

Introduction: Chronic immune sensorimotor polyradiculopathy (CISMP) is a chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) variant affecting both sensory and motor nerve roots without evidence of peripheral nerve demyelination.

Method: We report a case series of nine patients with CISMP, identified from two tertiary centers. Clinical, electrodiagnostic, and neuroradiologic features, and treatment responses, were retrospectively reviewed. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mus.26436
Publisher Site
http://dx.doi.org/10.1002/mus.26436DOI Listing
January 2019
4 Reads

Patterns of peripheral neuropathy in Sjogren's syndrome in a tertiary care hospital from South India.

Neurol India 2019 Jan-Feb;67(Supplement):S94-S99

Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

Introduction: Sjogren's syndrome (SS) is a systemic autoimmune disease that apart from involving the exocrine glands can affect any organ. Involvement of the peripheral nervous system results in a wide spectrum of neuropathic manifestations.

Objective: To evaluate the clinico-electrophysiological patterns as well as pathological characteristics of neuropathy in SS patients presenting to a neuromuscular clinic in a tertiary hospital from South India. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0028-3886.250714DOI Listing
January 2019
1 Read
1.084 Impact Factor

Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.

J Child Neurol 2019 Jan 23:883073818825213. Epub 2019 Jan 23.

2 Institute of Child Neurology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis in children. During the acute phase, the disorder can be life-threatening by involving the respiratory muscles and the autonomic nervous system. Nevertheless, the prognosis is good, and most children achieve full recovery. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0883073818825213
Publisher Site
http://dx.doi.org/10.1177/0883073818825213DOI Listing
January 2019
5 Reads

Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Neuroepidemiology 2019 Jan 22;52(3-4):161-172. Epub 2019 Jan 22.

Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Background: Prevalence and incidence rates of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are required to determine the impact of CIDP on society. We aimed to estimate the prevalence and incidence of CIDP worldwide and to determine the effect of diagnostic criteria on prevalence and incidence.

Method: A systematic review was conducted for all published incidence and prevalence studies on CIDP until May 18, 2017. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/494291
Publisher Site
http://dx.doi.org/10.1159/000494291DOI Listing
January 2019
11 Reads

Remarkable Rituximab Response on Tremor Related to Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4-Seropositive Patient.

Mov Disord Clin Pract 2018 Sep-Oct;5(5):559-560. Epub 2018 Aug 24.

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genova and IRCCS, Policlinico San Martino Genova Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207116PMC

Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy.

J Neurol Sci 2019 Feb 31;397:141-145. Epub 2018 Dec 31.

Department of Neurology and Neurophysiology, Amsterdam university medical centers, University of Amsterdam, Amsterdam, The Netherlands.

Intravenous immunoglobulins (IVIg) are an efficacious treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN). IVIg is considered in patients who have a high suspicion of an inflammatory neuropathy, but do not meet diagnostic criteria. The objective of this retrospective study was to assess which diagnostic results led to the decision to administer IVIg and to determine the rate of improvement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.12.036DOI Listing
February 2019
2 Reads

Anti-neurofascin autoantibody and demyelination.

Neurochem Int 2018 Dec 22. Epub 2018 Dec 22.

Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Demyelination diseases involving the central and peripheral nervous systems are etiologically heterogeneous with both cell-mediated and humoral immunities playing pathogenic roles. Recently, autoantibodies against nodal and paranodal proteins, such as neurofascin186 (NF186), neurofascin155 (NF155), contactin-1 (CNTN1), contactin-associated protein 1 (CASPR1) and gliomedin, have been discovered in not only chronic demyelinating conditions, such as multiple sclerosis (MS) and chronic inflammatory demyelinating polyradiculoneuropathy, but also in acute demyelinating conditions, such as Guillain-Barré syndrome. Only a minority of these patients harbor anti-nodal/paranodal protein antibodies; however, these autoantibodies, especially IgG4 subclass autoantibodies to paranodal proteins, are associated with unique features and these conditions are collectively termed nodopathy or paranodopathy. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01970186183043
Publisher Site
http://dx.doi.org/10.1016/j.neuint.2018.12.011DOI Listing
December 2018
9 Reads

Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy.

eNeurologicalSci 2018 Dec 22;13:38-39. Epub 2018 Nov 22.

Department of Neurology, University of Florida, Gainesville, FL 32610, United States.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired disorder of peripheral nerves and nerve roots. Its cause is unknown, but recently antibodies to nodal and paranodal proteins have been discovered in a small subset of CIDP patients. These contactin and neurofascin-related immune-mediated neuropathies are thought to be variants of CIDP and often respond suboptimally to standard therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ensci.2018.11.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275845PMC
December 2018
1 Read

Incomplete intestinal obstruction as an initial and persistent presentation in chronic inflammatory demyelinating polyneuropathy: A case report.

Medicine (Baltimore) 2018 Dec;97(49):e13538

Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei.

Rationale: Autonomic symptoms are not uncommon in chronic inflammatory demyelinating polyneuropathy (CIDP), but they are mostly mild and transient and are overshadowed by somatic manifestations. Here, we report a very unusual case of CIDP with severe autonomic symptom, intestinal obstruction, as initial and persistent symptom which responded well to high-dose glucocorticoid and intravenous immunoglobulin treatment.

Patient Concerns: We described a patient with CIDP with precedent and long-lasting incomplete intestinal obstruction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310579PMC
December 2018
3 Reads

Inflammatory demyelinating neuropathies with focal segmental glomerulosclerosis: Two case reports.

Medicine (Baltimore) 2018 Dec;97(49):e13304

Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.

Rationale: Inflammatory demyelinating neuropathies such as Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and focal segmental glomerulosclerosis (FSGS) are autoimmune disorders that may have a common pathogenesis. Here, we describe 2 unique cases of FSGS, 1 with GBS and the other with CIPD. We believe that reviewing these multisystemic diseases will help in better understanding of FSGS pathogenesis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310532PMC
December 2018
3 Reads

"Neuro-renal syndrome" related to anti-contactin-1 antibodies.

Muscle Nerve 2018 Nov 29. Epub 2018 Nov 29.

Institute for Neurosciences of Montpellier, INSERM U1051, Montpellier University, Hopital Gui de Chauliac, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26392DOI Listing
November 2018
2 Reads

High salt diet ameliorates functional, electrophysiological and histological characteristics of murine spontaneous autoimmune polyneuropathy.

Neurobiol Dis 2019 Apr 22;124:240-247. Epub 2018 Nov 22.

Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Klinik und Hochschulambulanz für Neurologie, Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Cluster of Excellence NeuroCure, Berlin, Germany; Berlin Institute of Health, 10178 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Center for Stroke Resarch Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Background: It was previously reported that high salt dietary conditions can drive autoimmunity and worsen severity and symptoms of autoimmune diseases. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a common autoimmune condition of the peripheral nervous system which leads to progressive paralysis and sensory deficits due to a demyelination and secondary axonal loss of peripheral nerves. We used a previously described model with a knockout of CD86 in non-obese diabetic mice (CD86 NOD), which results in the spontaneous development of an autoimmune peripheral neuropathy similar to CIDP and investigated the influence of a high salt diet on functional impairment, electrophysiological parameters, demyelination and neuroinflammation in these mice. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09699961183074
Publisher Site
http://dx.doi.org/10.1016/j.nbd.2018.11.017DOI Listing
April 2019
10 Reads

Expanded teased nerve fibre pathological conditions in disease association.

J Neurol Neurosurg Psychiatry 2019 Feb 1;90(2):138-140. Epub 2018 Nov 1.

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA

Objective: To describe an expanded teased nerve fibre classification in disease association.

Methods: We reviewed four newly proposed teased nerve fibre types (): Type J, rope-like fibres; K, fibril-like clumps of osmium positivity; L, cellular debris along and within nerve fibres; M, circular axonal inclusions surrounded by thin myelin. Different clinical pathological entities were studied for these fibre types including chronic inflammatory demyelinating polyradiculoneuropathy (CIDP: N=20); amyloid polyneuropathy (N=20); intraneural B-cell lymphoma (N=20) or adult-onset polyglucosan body disease (APBD: N=6) in comparison with 112 disease controls. Read More

View Article

Download full-text PDF

Source
http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-319077
Publisher Site
http://dx.doi.org/10.1136/jnnp-2018-319077DOI Listing
February 2019
11 Reads

Chronic inflammatory demyelinating polyradiculoneuropathy: A case report.

Medicine (Baltimore) 2018 Oct;97(41):e12469

Department of Neurology, The Second Affiliated Hospital of Nanchang University.

Rationale: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disorder characterized by a symmetrical, sensorimotor involvement and slowly progressive onset peripheral neuropathy. Peripheral neuropathies have been reported in some central demyelination patients. However, the central nervous system focus in the CIDP patient can mimic neuromyelitis optica have not been recognized by most of us. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000012469DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203576PMC
October 2018
7 Reads

Immune-mediated neuropathies.

Nat Rev Dis Primers 2018 Oct 11;4(1):31. Epub 2018 Oct 11.

Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Since the discovery of an acute monophasic paralysis, later coined Guillain-Barré syndrome, almost 100 years ago, and the discovery of chronic, steroid-responsive polyneuropathy 50 years ago, the spectrum of immune-mediated polyneuropathies has broadened, with various subtypes continuing to be identified, including chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN). In general, these disorders are speculated to be caused by autoimmunity to proteins located at the node of Ranvier or components of myelin of peripheral nerves, although disease-associated autoantibodies have not been identified for all disorders. Owing to the numerous subtypes of the immune-mediated neuropathies, making the right diagnosis in daily clinical practice is complicated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-018-0027-2DOI Listing
October 2018
3 Reads

Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies.

J Neurol 2018 Dec 10;265(12):2927-2933. Epub 2018 Oct 10.

Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Although anti-myelin-associated glycoprotein (MAG) antibody neuropathy is reported as a slowly progressive disease, it can lead to significant disability and impairment of health-related quality of life (HR-QoL) and social participation. The aim of this cross-sectional study was to evaluate the functioning and HR-QoL determinants in 67 patients with anti-MAG neuropathy in terms of the International Classification of Functioning, Disability, and Health (ICF). Evaluations included: Medical Research Council (MRC) sum score, Sensory Modality Sum score (SMS), Berg balance scale (BBS), Fatigue Severity Scale (FSS), Visual Analogue Scale (VAS) for pain, 9-Hole Peg Test (9-HPT), 6-min Walk Distance (6MWD), Impact on Participation and Autonomy (IPA) and the physical component score (PCS) and mental component score (MCS) of the short-form-36 health status scale (SF-36) HR-QoL measure. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-018-9081-7
Publisher Site
http://dx.doi.org/10.1007/s00415-018-9081-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244677PMC
December 2018
8 Reads

Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.

J Neurol Neurosurg Psychiatry 2019 Feb 8;90(2):125-132. Epub 2018 Oct 8.

Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Institute, Rozzano, Italy

Objectives: A few variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been described, but their frequency and evolution to typical CIDP remain unclear. To determine the frequency and characteristics of the CIDP variants, their possible evolution to typical CIDP, and treatment response.

Methods: We applied a set of diagnostic criteria to 460 patients included in a database of Italian patients with CIDP. Read More

View Article

Download full-text PDF

Source
http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-318714
Publisher Site
http://dx.doi.org/10.1136/jnnp-2018-318714DOI Listing
February 2019
22 Reads

[The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].

Zhonghua Nei Ke Za Zhi 2018 Oct;57(10):749-752

Department of Neurology, Peking University Third Hospital, Beijing 100191, China.

To explore clinical characteristics, electrophysiological findings and treatment response in diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy (DM-CIDP). Thirty-six CIDP patients were identified, 10 were DM-CIDP and 26 were non-DM-CIDP. Clinical medical records, electrophysiological data and treatment were retrospectively reviewed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0578-1426.2018.10.010DOI Listing
October 2018
3 Reads

Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.

J Neurol 2018 Dec 6;265(12):2906-2915. Epub 2018 Oct 6.

Universitätsklinik Ulm, RKU, Oberer Eselsberg 45, 89081, Ulm, Germany.

Objective: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, autoimmune-inflammatory disease of the peripheral nervous system. Recently, various immunoglobulin G4 (IgG4) type auto-antibodies have been described in patients with CIDP which can effectively be removed by immunoadsorption (IA). Therefore, we prospectively evaluated the therapeutic effect of IA in 17 patients with progressive CIDP not responding to other treatment. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-018-9082-6
Publisher Site
http://dx.doi.org/10.1007/s00415-018-9082-6DOI Listing
December 2018
1 Read

Ace the case: a 14-year-old with lower extremity weakness and blurry vision.

BMJ Case Rep 2018 Oct 2;2018. Epub 2018 Oct 2.

Department of Pediatrics, UNC Health Care System, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://casereports.bmj.com/lookup/doi/10.1136/bcr-2018-22653
Publisher Site
http://dx.doi.org/10.1136/bcr-2018-226535DOI Listing
October 2018
9 Reads

Proposal of new clinical diagnostic criteria for POEMS syndrome.

J Neurol Neurosurg Psychiatry 2019 Feb 2;90(2):133-137. Epub 2018 Oct 2.

Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

Objective: To propose the optimal diagnostic criteria for polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS) syndrome using appropriate statistical methods and disease controls.

Methods: This retrospective cohort study included 104 consecutive patients with suspected POEMS syndrome, among whom a gold standard group of 60 patients with definitive POEMS syndrome diagnosis were followed for at least 12 months to strictly exclude other disorders mimicking POEMS syndrome and to confirm response to POEMS syndrome-specific treatment. Thirty patients with chronic inflammatory demyelinating polyradiculoneuropathy (demyelinating polyradiculoneuropathy controls) and 30 with multiple myeloma or immunoglobulin light chain amyloidosis (monoclonal plasma cell proliferation controls) were also included. Read More

View Article

Download full-text PDF

Source
http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2018-318514
Publisher Site
http://dx.doi.org/10.1136/jnnp-2018-318514DOI Listing
February 2019
4 Reads

Simultaneous MR neurography and apparent T2 mapping in brachial plexus: Evaluation of patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Magn Reson Imaging 2019 Jan 25;55:112-117. Epub 2018 Sep 25.

Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Japan.

Purpose: MR neurography is known to be useful to evaluate nerve pathology. The purpose of this study was to evaluate the usefulness of simultaneous apparent T2 mapping and neurography with nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (SHINKEI) to distinguish patients with chronic inflammatory demyelinating polyneuropathy (CIDP) from healthy subjects.

Materials And Methods: This retrospective study included 13 patients with CIDP and five healthy subjects from 2015 to 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mri.2018.09.025DOI Listing
January 2019
7 Reads

[Immune-mediated / inflammatory and hereditary neuropathies - overview and diagnostic algorithm].

Fortschr Neurol Psychiatr 2018 09 24;86(9):566-574. Epub 2018 Sep 24.

Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, Klinikum der LMU München.

This paper is a practical survey of immune-mediated, inflammatory and hereditary neuropathies along with recommendations for diagnostic procedures. The large group of immune-mediated, inflammatory neuropathies includes the Guillain-Barré syndrome and chronic-inflammatory demyelinating polyradiculoneuropathy and their subtypes, vasculitic, paraneoplastic and paraproteinemic neuropathies as well as neuropathies resulting from connective tissue disorders. Besides clinical features such as time-dependent progression and distribution of sensorimotor deficits, characteristic electroneurographic findings and antibody profiles are considered. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0655-7659DOI Listing
September 2018
2 Reads

Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.

Brain Behav 2018 Oct 21;8(10):e01115. Epub 2018 Sep 21.

Department of Neurology, the First Affiliated Hospital of China Medical University, Shenyang, China.

Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most commonly observed phenotype among chronic acquired demyelinating polyneuropathies and is clinically variable. The aim of this meta-analysis was to evaluate the diagnostic value and characteristics of CIDP targeting neurofascin 155 (NF155).

Methods: A systematic literature search was performed on March 2018, and two reviewers independently extracted data and assessed the risk of bias on MEDLINE, EMBASE, the Web of Science, and the Cochrane Library to identify relevant articles. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/brb3.1115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192399PMC
October 2018
1 Read

Assessing the benefit of treatment in chronic inflammatory demyelinating polyneuropathy: the challenges of clinical practice.

Neurodegener Dis Manag 2018 10 18;8(5):285-288. Epub 2018 Sep 18.

Aston Brain Centre, School of Life & Health Sciences, Aston University, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt-2018-0027DOI Listing
October 2018

Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases.

J Peripher Nerv Syst 2018 Dec 7;23(4):235-240. Epub 2018 Oct 7.

Department of Clinical Neurophysiology, APHP, Pitié-Salpêtrière Hospital, Paris, France.

We aimed to analyse the response to rituximab in a cohort of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients with associated disorders. We conducted a clinical and electrophysiological retrospective monocentric study in 28 CIDP patients. Response to rituximab was defined as (a) a five-point increase in the Medical Research Council sum score or a one-point decrease in the Overall Neuropathy Limitations Scale score, compared to the score at the first rituximab infusion, or (b) the discontinuation of, or reduced need for, the last treatments before rituximab initiation. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jns.12287
Publisher Site
http://dx.doi.org/10.1111/jns.12287DOI Listing
December 2018
5 Reads

Lumbar plexus in patients with chronic inflammatory demyelinating polyradiculoneuropathy: evaluation with simultaneous T mapping and neurography method with SHINKEI.

Br J Radiol 2018 Dec 17;91(1092):20180501. Epub 2018 Sep 17.

2 Clinical Radiology, Graduate School of Medical Sciences, Kyushu University , Fukuoka , Japan.

Objective:: To evaluate the usefulness of simultaneous T mapping and neurography with nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (SHINKEI) in the lumbar plexus to distinguish patients with chronic inflammatory demyelinating polyneuropathy (CIDP) from healthy controls.

Methods:: Our institutional review boards approved this retrospective study, and written informed consent was waived. 10 patients with CIDP from 2015 to 2017 were studied along with 5 healthy controls on a 3 T scanner. Read More

View Article

Download full-text PDF

Source
https://www.birpublications.org/doi/10.1259/bjr.20180501
Publisher Site
http://dx.doi.org/10.1259/bjr.20180501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319828PMC
December 2018
10 Reads

Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.

J Clin Neurosci 2018 Nov 23;57:198-201. Epub 2018 Aug 23.

Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Diabetic patients with poor glycaemic control can demonstrate demyelinating distal sensorimotor polyneuropathy (D-DSP) on electrophysiology. Distinguishing D-DSP from chronic inflammatory demyelinating polyneuropathy (CIDP) can be challenging. In this study, we investigated the role of nerve ultrasound in differentiating the two neuropathies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2018.08.031DOI Listing
November 2018
2 Reads

POEMS syndrome.

Curr Opin Neurol 2018 Oct;31(5):551-558

Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

Purpose Of Review: To provide an overview of polyneuropathy organomegaly endocrinopathy M-protein and skin changes (POEMS) syndrome, detailing new insights into pathogenesis, prognostic factors, treatments, and outcome scores.

Recent Findings: With the development of large multicentre national cohorts of patients, POEMS syndrome is evolving into a well characterized multisystem hematoneurological syndrome. Without early diagnosis significant disability results from the neuropathy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000610DOI Listing
October 2018
18 Reads

CIDP, myasthenia gravis, and membranous glomerulonephritis - three autoimmune disorders in one patient: a case report.

BMC Neurol 2018 Aug 14;18(1):113. Epub 2018 Aug 14.

Department of Neurology, Essen University Hospital, Hufelandstrasse 55, 45147, Essen, Germany.

Background: We present a patient fulfilling the electrophysiological criteria for definite chronic inflammatory demyelinating polyneuropathy (CIDP), antibody-positive myasthenia gravis (MG), and membranous glomerulonephritis (MGN) confirmed by biopsy. To our knowledge, this is the first case of the concomitant appearance of these three autoimmune diseases in a single patient.

Case Representation: A 42-year-old Caucasian male presented with rapidly progressive gait disturbance, distal weakness of the lower extremities, ascending hypoesthesia, impaired fine motor skills, and beginning cranial nerve palsy showing dysarthrophonia, facial paralysis, and eye movement abnormalities and was diagnosed as rapid onset (atypical) CIDP. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-018-1120-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092826PMC
August 2018
7 Reads

Nerve and skin biopsy in neuropathies.

Authors:
Claudia Sommer

Curr Opin Neurol 2018 Oct;31(5):534-540

Department of Neurology, University of Würzburg, Würzburg, Germany.

Purpose Of Review: To give an overview of recent data on the use of nerve and skin biopsy as a diagnostic tool in neuropathies.

Recent Findings: Axonal damage in a biopsy from a patient with chronic inflammatory demyelinating polyradiculoneuropathy may point to the presence of autoantibodies to paranodal proteins. In nonsystemic vasculitis of the peripheral nervous system, nerve biopsy is still the only means to make a definite diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000601DOI Listing
October 2018
7 Reads

Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.

Neuromuscul Disord 2018 Sep 12;28(9):757-765. Epub 2018 Jun 12.

The Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, 30 Guilford St, London, and MRC Centre for Neuromuscular Diseases & Neuroscience Unit, Great Ormond Street Hospital, London, UK.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a treatable chronic disorder of the peripheral nervous system. We retrospectively studied 30 children with a suspected diagnosis of CIDP. The diagnosis of CIDP was compared against the childhood CIDP revised diagnostic criteria 2000. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09608966173155
Publisher Site
http://dx.doi.org/10.1016/j.nmd.2018.06.001DOI Listing
September 2018
8 Reads

Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases.

Autoimmun Rev 2018 Sep 10;17(9):873-881. Epub 2018 Jul 10.

AP-HP, Pitié-Salpetrière Hospital, Department of Internal Medicine and Clinical Immunology, Paris, France.

We reviewed the efficacy of SCIg administration in terms of muscle strength maintenance and patient satisfaction comparing with IVIg in the treatment of auto-immune neuromuscular diseases. A systematic review was conducted, and identified studies from databases (PUBMED, EMBASE, EBSCO, Web of Science and Google Scholar) which were analyzed. The methodological quality of the selected publications was evaluated using the Newcastle-Ottawa Scale. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2018.03.010DOI Listing
September 2018
37 Reads

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.

Lancet Neurol 2018 Aug 9;17(8):689-698. Epub 2018 Jul 9.

Department of Neurology, Universitätsklinikum Düsseldorf and Center for Neurology and Neuropsychiatry LVR Klinikum, Heinrich-Heine-University, Düsseldorf, Germany.

Background: Fingolimod is approved for the treatment of relapsing-remitting multiple sclerosis and was effective in experimental autoimmune neuritis in rats, a possible model for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). We aimed to evaluate the efficacy of fingolimod in delaying disability progression in patients with CIDP who withdrew from currently effective treatments (intravenous immunoglobulin [IVIg] or corticosteroids).

Methods: This double-blind, multicentre, randomised, placebo-controlled, parallel-group, event-driven study was done at 48 neurology centres in Australia, Canada, Israel, Japan, the USA, and nine countries in Europe. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(18)30202-3DOI Listing
August 2018
25 Reads

Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.

J Peripher Nerv Syst 2018 Sep 29;23(3):178-182. Epub 2018 Jul 29.

Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.

It has been previously shown that patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who are unemployed or retired have worse quality of life. The aim of this study was to assess predictors of early retirement in CIDP. One hundred five patients with CIDP were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jns.12281DOI Listing
September 2018
10 Reads

Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype.

Clin Neurol Neurosurg 2018 Sep 3;172:90-92. Epub 2018 Jul 3.

Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Electronic address:

We herein report the first combined central and peripheral demyelination (CCPD) case originally diagnosed as multifocal acquired demyelinating sensory and motor neuropathy followed by CNS impairments with a long lag time (160 days after first attack). The anti-neutral glycolipids antibodies, especially anti-lactosylceramide antibodies but not anti-NF155 antibodies typical for CCPD were detected in the acute phase of sera and cerebrospinal fluid (CSF) and disappeared in the recovery phase. This case strongly illustrated the significance of examining anti-neutral glycolipids antibodies in future anti-NF 155 antibodies-negative CCPD cases. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03038467183026
Publisher Site
http://dx.doi.org/10.1016/j.clineuro.2018.06.046DOI Listing
September 2018
7 Reads

Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone.

J Neurol 2018 Sep 2;265(9):2052-2059. Epub 2018 Jul 2.

Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) can be treated with corticosteroids or intravenous immunoglobulins. Various corticosteroid regimens are currently used in CIDP, but it is unknown whether they are equally efficacious. In this retrospective study, we compared efficacy and safety of three corticosteroid regimens in CIDP patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-018-8948-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132640PMC
September 2018
13 Reads

Myelitis and Polyradiculoneuropathy With Severe Pain: Unusual Neurological Manifestations as Presenting Symptoms of Brucellosis.

Neurologist 2018 Jul;23(4):131-134

Departments of Neurology.

Brucellosis, an endemic zoonosis in Portugal, is a multisystem disease, presenting with neurological manifestations in up to 25% of cases. Neurobrucellosis diagnostic criteria include evidence of central nervous system invasion, either by documenting increased blood-brain barrier permeability that normalizes after treatment or by Brucella isolation. We report 2 patients with systemic brucellosis presenting with neurological symptoms: A 28-year-old female with progressive hemiparesis associated with severe refractory thoracic and lumbar pain, whose spinal magnetic resonance imaging identified longitudinally extensive myelitis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NRL.0000000000000184DOI Listing
July 2018
19 Reads

Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique.

J Neurol 2018 Aug 20;265(8):1916-1921. Epub 2018 Jun 20.

Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Objective: To assess the value of triple stimulation technique (TST) for diagnose of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Methods: Seven clinically suspected CIDP patients who did not fulfill EFNS/PNS electrodiagnostic criteria for demyelinating neuropathy were enrolled in our study. Routine nerve conduction studies, lumbar puncture, spinal cord magnetic resonance imaging and TST were detected. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-018-8929-1DOI Listing
August 2018
7 Reads

Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy.

Muscle Nerve 2018 Sep;58(3):407-412

Department of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea.

Introduction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients possess multiple risk factors for osteoporosis, but few studies have evaluated bone mineral density (BMD) in CIDP patients.

Methods: We retrospectively compared the BMD of CIDP patients with that of normal controls, and evaluated the clinical factors associated with osteoporosis.

Results: Total BMD was lower in CIDP patients than in normal controls (P = 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26175DOI Listing
September 2018
1 Read

An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies.

J Autoimmun 2018 Aug 5;92:114-125. Epub 2018 Jun 5.

Fédération de Médecine Translationnelle de Strasbourg (FMTS), France; CNRS UMR7242 Biotechnology and Cell Signaling, University of Strasbourg, France /Laboratory of Excellence Medalis, France; University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France. Electronic address:

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nerves evolving with diffuse sensory and motor symptoms. Although it is claimed that in neurodegenerative pathologies, a common feature is the failure of proteolytic systems to adequately eliminate aggregated or misfolded proteins, it has not been addressed whether autophagy, a central "clearance" system delivering damaged intracellular components to lysosomes, is affected in CIDP. The focus of the present investigation was therefore to determine if some defects exist in autophagy processes in this setting and if they can be corrected or minimized using an appropriate treatment targeting this survival pathway. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2018.05.009DOI Listing
August 2018
4 Reads
8.410 Impact Factor

History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Mayo Clin Proc 2018 Jun;93(6):777-793

Department of Neurology, Mayo Clinic, Rochester, MN.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is probably the best recognized progressive immune-mediated peripheral neuropathy. It is characterized by a symmetrical, motor-predominant peripheral neuropathy that produces both distal and proximal weakness. Large-fiber abnormalities (weakness and ataxia) predominate, whereas small-fiber abnormalities (autonomic and pain) are less common. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2018.03.026DOI Listing
June 2018
12 Reads

[Diabetic and non-diabetic neuropathies in patients with diabetes mellitus].

Zh Nevrol Psikhiatr Im S S Korsakova 2018;118(4):113-120

Sechenov First Moscow State Medical University, Moscow, Russia.

Diabetic polyneuropathy is the most often complication of diabetes mellitus. However, patients with diabetes may have other neuropathies, which need to be recognized and treated. Chronic nnflammatory demyelinating polyneuropathy is the most common non-diabetic polyneuropathy in patients with diabetes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17116/jnevro201811841113-120DOI Listing
January 2018
3 Reads

Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence.

Clin Exp Rheumatol 2019 Jan-Feb;37(1):146-155. Epub 2018 May 24.

Department of Medical Science, Section of Rheumatology, University of Ferrara and Azienda Ospedaliero-Universitaria S.Anna, Cona, Ferrara, Italy.

In the past years the peripheral nervous system (PNS) involvement in systemic lupus erythematosus (SLE) has received little attention despite its potential significant impact. The true prevalence of PNS in SLE reported in studies is variable and strongly influenced by American College of Rheumatology (ACR) case definition that includes seven PNS manifestations (acute inflammatory demyelinating polyradiculoneuropathy, autonomic disorder, mononeuropathy, myasthenia gravis, cranial neuropathy, plexopathy and polyneuropathy). Other peripheral manifestations, such as chronic inflammatory demyelinating polyradiculoneuropathy and small fibre neuropathy, not included in the ACR nomenclature, have not been well characterised in SLE. Read More

View Article

Download full-text PDF

Source
May 2018
5 Reads

CD59 deficiency presenting as polyneuropathy and Moyamoya syndrome with endothelial abnormalities of small brain vessels.

Eur J Paediatr Neurol 2018 Sep 13;22(5):870-877. Epub 2018 Apr 13.

Center for Pediatrics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Center for Pediatrics, Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

CD59 is involved in lymphocyte signal transduction and regulates complement-mediated cell lysis by inhibiting the membrane attack complex. In the cases reported so far, congenital isolated CD59 deficiency was associated with recurrent episodes of hemolytic anemia, peripheral neuropathy, and strokes. Here, we report on a patient from a consanguineous Turkish family, who had a first episode of hemolytic anemia at one month of age and presented at 14 months with acute Guillain-Barré syndrome (GBS). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejpn.2018.04.003DOI Listing
September 2018
19 Reads

IgPro20, the Polyneuropathy and Treatment with Hizentra study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG.

Immunotherapy 2018 Aug 16;10(11):919-933. Epub 2018 May 16.

CSL Behring, GmbH. Marburg, Germany.

Subcutaneous IgG (SCIG) administration may be preferred over the intravenous route (IVIG) in chronic inflammatory demyelinating polyneuropathy (CIDP) because it minimizes 'end of cycle' treatment-related fluctuations, reduces systemic adverse effects, improves convenience/quality of life and potentially lowers overall costs. Early reports of the use of highly concentrated SCIG preparations suggested they were effective and well-tolerated in chronic inflammatory demyelinating polyneuropathy. This was confirmed in the Polyneuropathy and Treatment with Hizentra study of 172 subjects randomized to receive maintenance therapy with placebo or one of two doses of IgPro20 (20% IgG stabilized with L-Proline) for 6 months. Read More

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0036
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0036DOI Listing
August 2018
3 Reads

Smoothing the transition process Caitlin's legacy.

Authors:
Sarah Jones

J Fam Health 2017 May;27(3):26-28

View Article

Download full-text PDF

Source